PROCW
Procaps Group S.A. WarrantsKey Statistics
About Procaps Group S.A. Warrants
Procaps Group S.A. Warrants (PROCW) represents a strategic opportunity for investors seeking exposure to the rapidly growing pharmaceutical and health supplements sector in Latin America. Procaps is a prominent integrated healthcare company known for its innovative delivery technologies and high-quality products, which include prescription medications, over-the-counter remedies, and dietary supplements. With a strong commitment to R&D and a robust distribution network, Procaps is well-positioned to capitalize on the increasing demand for health and wellness solutions. As it continues to expand its product offerings and geographic reach, PROCW warrants consideration for investors looking to leverage the growth potential in the health sector.
Fundamentals
| Revenue (TTM) | $414.10M |
| Gross Profit (TTM) | $227.91M |
| EBITDA | $57.06M |
| Operating Margin | 11.10% |
| Return on Equity | 37.40% |
| Return on Assets | 6.28% |
| Revenue/Share (TTM) | $4.10 |
| Book Value | $0.39 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -63.70% |
| Quarterly Revenue Growth (YoY) | 7.30% |
| Shares Outstanding | 0 |
| Float | $17.15M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting